Board of Directors for Covetrus named

Henry Schein, Inc. and Vets First Choice have name their designees for the board of directors of the new public company created from the spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice.
Co-Founder and chairman of Vets First Choice, David E. Shaw, will become chairman of the board of Covetrus. He has helped build a number of successful science-based companies including Ikaria and IDEXX. Mr Shaw said: “Our intention has been to create a board that reflects the expansive and transformative nature of the Covetrus opportunity, and we believe that this slate of nominees achieves that in terms of caliber, diversity, independence and other qualities. This group has a strong mix of relevant experience, global domain knowledge and extensive capabilities across key board functions that will help Covetrus scale its technology-enabled services platform across the globe and deliver upon its mission of advancing the world of veterinary medicine.”
Philip A. Laskawy, a former partner, chairman and CEO of the accounting firm EY LLP, and currently the Lead Independent Director on Henry Schein’s board of directors, will serve as Lead Independent Director of Covetrus. Mr Laskawy said: “It is an honor to be entrusted with the role of Lead Independent Director and to join a team of such high-quality directors. At Covetrus, we will have a firm commitment to strong corporate governance as we focus on instilling a framework of accountability that drives long-term value creation.”